Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Washington

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Urology|February 6, 2017
Cystoscopic Evaluation of Bladder LeiomyomaSamuel L Washington, Arash Eslami, David T Tzou
Current Opinion in Urology|February 25, 2017
Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?Selma Masic, Samuel L Washington, Peter R Carroll
The Journal of Urology|November 17, 2022
Urologists in Advocacy: The Key to Addressing Disparities in Prostate CancerAshley Pittman, Kelvin A Moses, Samuel L Washington
European Urology Focus|September 23, 2019
What is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients?Samuel L Washington, Yaw A Nyame, Kelvin A Moses
Nature Reviews. Urology|November 29, 2024
Time is on our side - rethinking the concept of time to treatment for prostate cancerNynikka R Palmer, Peter R Carroll, Samuel L Washington
The Journal of Urology|December 30, 2021
Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate CancerSamuel L Washington, John L Gore, Yaw A Nyame
The Urologic Clinics of North America|June 26, 2026
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive DiseaseSha Zhu, Samuel L Washington, Rishi Sekar, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2019
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder CancerSamuel L Washington, John Neuhaus, Maxwell V Meng, et al.
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Urology|February 6, 2017
Cystoscopic Evaluation of Bladder LeiomyomaSamuel L Washington, Arash Eslami, David T Tzou
Current Opinion in Urology|February 25, 2017
Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?Selma Masic, Samuel L Washington, Peter R Carroll
The Journal of Urology|November 17, 2022
Urologists in Advocacy: The Key to Addressing Disparities in Prostate CancerAshley Pittman, Kelvin A Moses, Samuel L Washington
European Urology Focus|September 23, 2019
What is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients?Samuel L Washington, Yaw A Nyame, Kelvin A Moses
Nature Reviews. Urology|November 29, 2024
Time is on our side - rethinking the concept of time to treatment for prostate cancerNynikka R Palmer, Peter R Carroll, Samuel L Washington
The Journal of Urology|December 30, 2021
Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate CancerSamuel L Washington, John L Gore, Yaw A Nyame
The Urologic Clinics of North America|June 26, 2026
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive DiseaseSha Zhu, Samuel L Washington, Rishi Sekar, et al.
Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2019
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder CancerSamuel L Washington, John Neuhaus, Maxwell V Meng, et al.
The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.
Pageof 12